RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells
[EN] BackgroundThe eukaryotic translation initiation protein eIF5A is a highly conserved and essential factor that plays a critical role in different physiological and pathological processes including stress response and cancer. Different proteomic studies suggest that eIF5A may be a small ubiquitin-like modifier (SUMO) substrate, but whether eIF5A is indeed SUMOylated and how relevant is this modification for eIF5A activities are still unknown.MethodsSUMOylation was evaluated using in vitro SUMOylation assays, Histidine-tagged proteins purification from His6-SUMO2 transfected cells, and isolation of endogenously SUMOylated proteins using SUMO-binding entities (SUBES). Mutants were engineered by site-directed mutagenesis. Protein stability was measured by a cycloheximide chase assay. Protein localization was determined using immunofluorescence and cellular fractionation assays. The ability of eIF5A1 constructs to complement the growth of Saccharomyces cerevisiae strains harboring thermosensitive mutants of a yeast EIF5A homolog gene (HYP2) was analyzed. The polysome profile and the formation of stress granules in cells expressing Pab1-GFP (a stress granule marker) by immunofluorescence were determined in yeast cells subjected to heat shock. Cell growth and migration of pancreatic ductal adenocarcinoma PANC-1 cells overexpressing different eIF5A1 constructs were evaluated using crystal violet staining and transwell inserts, respectively. Statistical analysis was performed with GraphPad Software, using unpaired Student's t-test, or one-way or two-way analysis of variance (ANOVA).ResultsWe found that eIF5A is modified by SUMO2 in vitro, in transfected cells and under endogenous conditions, revealing its physiological relevance. We identified several SUMO sites in eIF5A and found that SUMOylation modulates both the stability and the localization of eIF5A in mammalian cells. Interestingly, the SUMOylation of eIF5A responds to specific stresses, indicating that it is a regulated process. SUMOylation of eIF5A is conserved in yeast, the eIF5A SUMOylation mutants are unable to completely suppress the defects of HYP2 mutants, and SUMOylation of eIF5A is important for both stress granules formation and disassembly of polysomes induced by heat-shock. Moreover, mutation of the SUMOylation sites in eIF5A abolishes its promigratory and proproliferative activities in PANC-1 cells.ConclusionsSUMO2 conjugation to eIF5A is a stress-induced response implicated in the adaptation of yeast cells to heat-shock stress and required to promote the growth and migration of pancreatic ductal adenocarcinoma cells., Open Access funding was provided thanks to the CRUE-CSIC agreement with Springer Nature.
Funding at the laboratory of CR is provided by the Ministry of Science, Innovation and Universities and FEDER (BFU-2017-88880-P, PID2021-126510NBI00), and by the Xunta de Galicia (ED431G 2023/10).
RS, SV and TLD are predoctoral fellows funded by the Xunta de Galicia – Consellería de Cultura, Educación y Ordenación Universitaria (ED481A-2020/160, ED481A-2018/110, and ED481A-2018/042, respectively).
AMR is a postdoctoral fellow funded by the Generalitat Valenciana (CIAPOS2021/117).
MB is a predoctoral fellow funded by Banco Santander and the University of Santiago de Compostela.
RMT is a predoctoral fellow funded by the Instituto de Investigación Sanitaria de Santiago de Compostela.
The Blanco lab is supported by MCIN/AEI/https://doi.org/10.13039/501100011033
(PID2020-115472GB-I00) and by the Xunta de Galicia/FEDER – Una manera de hacer Europa (ED431C 2019/013).
The RF lab is supported by the Fondo de Investigación Sanitaria, ISCIII (PI20-00194).
The PA lab is supported by MCIN/AEI/https://doi.org/10.13039/501100011033
(PID2020-120066RB-I00) and by GVA CIAICO/2022/237.
AMF is a predoctoral fellow funded by the Asociación Española Contra el Cáncer (AECC APRO 2018).
RB and JDS thank MCIN/AEI/https://doi.org/10.13039/501100011033
(PID2020-114178GB-I00, CEX2021-001136-S).
Finally, CR, RF and RB acknowledge support from SAF2017-90900-REDT (UBIRed Program, Spain) and COST Action ProteoCure CA20113.
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 BFU2017-88880-P
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-114178GB-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-115472GB-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-120066RB-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126510NB-I00
,
Xunta de Galicia / COST Action ED481A-2020/160
,
Xunta de Galicia / Centros de Excelencia Severo Ochoa y Unidades Ramiro de Maeztu ED481A-2018/110
,
Xunta de Galicia / Redes de investigación y Redes de excelencia ED481A-2018/042
,
Xunta de Galicia ED431G 2023/10
,
Xunta de Galicia ED431C 2019/013
,
Generalitat Valenciana CIAICO/2022/237
,
Generalitat Valenciana CIAPOS/2021/117
,
European Cooperation in Science and Technology CA20113
,
Agencia Estatal de Investigación CEX2021-001136-S
,
Agencia Estatal de Investigación SAF2017-90900-REDT